GSK PHARMA

Domestic pharmaceutical retail market grows 11 per cent in July

Acute therapy, including pain and anti-infectives reported a growth of 11 per cent, while chronic medication, mainly anti-diabetics and cardio-vascular, grew 12 per cent. Among the companies, Sun Pharma maintained its top position with a market share of 8 per cent during July, the data said.

More in GSK PHARMA

GSK Pharma's net profit falls 3.9 pc to Rs 150.3 cr in Dec quarter

Total income in October-December 2021 stood at Rs 826.24 crore as compared with Rs 805.89 crore in the year-ago period, it added.
Cipla scales up offerings, investments as it eyes global lung specialty leadership

Drugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become the number one company in lung specialty.
Costs of raw material for drugs rise by 139%

A steep rise in the cost of raw materials for essential drugs, called active pharmaceutical ingredients (API) in pharma circles, by 139% in certain cases since the pre-pandemic level, is pinching the industry hard.
GSK Pharma board approves sale of Vemgal plant to Hetero Labs

The board of directors at its meeting held on Tuesday, approved the sale of the company's business undertaking i.e., manufacturing facility together with the land, plant and machinery, assets, software and equipment located at Vemgal, Karnataka, to Hetero Labs Ltd.
GSK announces sale of Vemagal plant; takes Rs 640 crore hit on account of Zinetac recall

The decision was taken on account of the financial impact of voluntary recall of popular heartburn medicine ranitidine, Zinetac in India.
GSK Pharma Q2 profit down 23% to Rs 101 cr

The company had posted a net profit of Rs 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.
GSK Pharma to sell land in Thane to Oberoi Realty for Rs 555cr

GlaxoSmithKline (GSK) Pharmaceuticals said in a BSE filing.
GSK Pharma to invest Rs 1K cr in Karnataka plant

GlaxoSmithKline Pharmaceuticals Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India.
Cadila, Torrent Pharma, GSK in race for top-selling multivitamin brand

Apex Labs pioneered the introduction of zinc-based formulations in the Indian market and the company's flagship brand Zincovit is the brand leader in its segment with a 19% market share, according to the company website.
Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issues

While most pharma companies have turned risky on account of regulatory clamps, investors have switched to companies with healthy pipeline and strong track record with FDA.
GSK Pharma trying to find out what ammunition is needed to grow: MD

The Indian arm of British drugmaker GlaxoSmithKline (GSK) is planning a major initiative to wrestle back ground it had conceded.